Apellis Pharmaceuticals Inc. (APLS)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
VenBio Select Advisor

Kurt Von Emster

10,125,000 $691,538 +4% 12.77%
2.
EcoR1 Capital

Oleg Nodelman

5,183,431 $354,028 10.44%
3. 2,503,059 $170,959 -4% 29.5%
4. 1,478,000 $100,947 +56% 7.05%
5.
Deerfield ManagementNOTE 3.500% 9/1

James E. Flynn

51,885,000 $99,115 1.97%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$40.00 250,000 Large Shareholder 12,806,342 2021-11-18 Filing
$31.81 5,000 Director 5,000 2020-05-08 Filing
$37.00 540,540 Large Shareholder 12,556,342 2020-01-13 Filing
$29.71 11,699 Officer 11,699 2019-08-29 Filing
$17.00 441,176 Large Shareholder 12,015,802 2019-03-11 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$49.93 500 Director 129,430 2022-12-01 Filing
$49.93 2,500 Officer 97,384 2022-12-01 Filing
$48.01 1,250 Director 263,774 2022-11-15 Filing
$46.47 12,000 Officer 963,780 2022-11-08 Filing
$58.54 5,000 Officer 42,907 2022-11-03 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 12,500,000 $24,423,875 0.01%
2. 168,971 $11,540,719 0.12%
3. 115,362 $7,879,225 0.01%
4. 69,158 $4,723,491 0%
5. 9,957,416 $680,091 0.14%
News See All